Start with a lower concentration (0.51%) if you're new to formulation, then adjust based on skin response
Why this matters: Lanifibranor (a pan-PPAR agonist in Phase 3 for MASH) works but requires high systemic doses that cause weight gain, fluid retention, and anemia
Canadian adult obesity clinical practice guidelines: pharmacotherapy in obesity management
Wegovy also contains warnings for inflammation of the pancreas (pancreatitis), gallbladder problems (including gallstones), low blood sugar, acute kidney injury, hypersensitivity reactions, diabetic retinopathy (damage to the eyes retina), increased heart rate and suicidal behavior or thinking
BPC-157 is right up there as a top pick for protocols, but sorting out sourcing is the real challenge
Effective Strategies to Manage Nausea Now that we understand the underlying mechanisms of nausea, lets explore actionable strategies to alleviate this common side effect